Article Versions Notes

Liu Y-C, Peng B-R, Hsu K-C, El-Shazly M, Shih S-P, Lin TE, Kuo F-W, Chou Y-C, Lin H-Y, Lu M-C. 13-Acetoxysarcocrassolide Exhibits Cytotoxic Activity against Oral Cancer Cells through the Interruption of the Keap1/Nrf2/p62/SQSTM1 Pathway: The Need to Move Beyond Classical Concepts. Marine Drugs. 2020; 18(8):382. https://doi.org/10.3390/md18080382

Liu, Yi-Chang, Bo-Rong Peng, Kai-Cheng Hsu, Mohamed El-Shazly, Shou-Ping Shih, Tony Eight Lin, Fu-Wen Kuo, Yi-Cheng Chou, Hung-Yu Lin, and Mei-Chin Lu. 2020. "13-Acetoxysarcocrassolide Exhibits Cytotoxic Activity against Oral Cancer Cells through the Interruption of the Keap1/Nrf2/p62/SQSTM1 Pathway: The Need to Move Beyond Classical Concepts" Marine Drugs 18, no. 8: 382. https://doi.org/10.3390/md18080382

Liu, Y. -C., Peng, B. -R., Hsu, K. -C., El-Shazly, M., Shih, S. -P., Lin, T. E., Kuo, F. -W., Chou, Y. -C., Lin, H. -Y., & Lu, M. -C. (2020). 13-Acetoxysarcocrassolide Exhibits Cytotoxic Activity against Oral Cancer Cells through the Interruption of the Keap1/Nrf2/p62/SQSTM1 Pathway: The Need to Move Beyond Classical Concepts. Marine Drugs, 18(8), 382. https://doi.org/10.3390/md18080382